These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9509064

  • 1. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I, Hinton DR, Weiss MH, Melmed S.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
    [Abstract] [Full Text] [Related]

  • 2. Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.
    Shimon I, Hüttner A, Said J, Spirina OM, Melmed S.
    J Clin Invest; 1996 Jan 01; 97(1):187-95. PubMed ID: 8550832
    [Abstract] [Full Text] [Related]

  • 3. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
    Turner HE, Nagy Z, Sullivan N, Esiri MM, Wass JA.
    Clin Endocrinol (Oxf); 2000 Sep 01; 53(3):337-44. PubMed ID: 10971451
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study.
    Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos N, Woolley J, Besser GM, Grossman A.
    Clin Endocrinol (Oxf); 1992 Aug 01; 37(2):163-7. PubMed ID: 1327588
    [Abstract] [Full Text] [Related]

  • 5. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W, Ikeda H, Yoshimoto T.
    Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.
    Komatsubara K, Tahara S, Umeoka K, Sanno N, Teramoto A, Osamura RY.
    Endocr Pathol; 2001 Jul 15; 12(2):181-8. PubMed ID: 11579684
    [Abstract] [Full Text] [Related]

  • 7. The release of leptin and its effect on hormone release from human pituitary adenomas.
    Korbonits M, Chitnis MM, Gueorguiev M, Norman D, Rosenfelder N, Suliman M, Jones TH, Noonan K, Fabbri A, Besser GM, Burrin JM, Grossman AB.
    Clin Endocrinol (Oxf); 2001 Jun 15; 54(6):781-9. PubMed ID: 11422113
    [Abstract] [Full Text] [Related]

  • 8. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B, Korbonits M, Diaz-Cano S, Kaltsas G, Morris DG, Jordan S, Metherell L, Powell M, Czirják S, Arnaldi G, Bustin S, Boscaro M, Mantero F, Grossman AB.
    Clin Endocrinol (Oxf); 2003 Sep 15; 59(3):328-38. PubMed ID: 12919156
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P, Boccardi E, Branca V, Bramerio M, Barberis M, Losa M, Terreni MT, Lodrini S, Pollo B, Vignati F.
    Clin Endocrinol (Oxf); 1998 Oct 15; 49(4):433-9. PubMed ID: 9876339
    [Abstract] [Full Text] [Related]

  • 10. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
    Yamada S, Takahashi M, Hara M, Hattori A, Sano T, Ozawa Y, Shishiba Y, Hirata K, Usui M.
    Clin Endocrinol (Oxf); 1996 Sep 15; 45(3):263-72. PubMed ID: 8949563
    [Abstract] [Full Text] [Related]

  • 11. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I, Bácsy E, Varga I, Slowik F, Bálint K, Pásztor E, Czirják S, Gláz E.
    Folia Histochem Cytobiol; 2000 Sep 15; 38(3):119-27. PubMed ID: 10970071
    [Abstract] [Full Text] [Related]

  • 12. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA, Schramm J, Redel L, Neuloh G, Wichers M, Klingmüller D.
    Acta Neurochir (Wien); 2002 Jun 15; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [Abstract] [Full Text] [Related]

  • 13. Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.
    Chauvet N, Romanò N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, Osterstock G, Osterstock P, Baccino E, Rigau V, Loiseau H, Bouillot-Eimer S, Barlier A, Mollard P, Coutry N.
    J Neuroendocrinol; 2016 Feb 15; 28(2):12352. PubMed ID: 26686489
    [Abstract] [Full Text] [Related]

  • 14. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
    Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Ruggeri A, Peciarolo A.
    Tumori; 2000 Feb 15; 86(3):229-32. PubMed ID: 10939604
    [Abstract] [Full Text] [Related]

  • 15. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
    Jones TH, Figueroa CD, Smith CM, Cullen DR, Bhoola KD.
    J Endocrinol; 1992 Jul 15; 134(1):149-54. PubMed ID: 1500840
    [Abstract] [Full Text] [Related]

  • 16. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K, Kubo O, Tajika Y, Huang MC, Takakura K.
    No To Shinkei; 1996 Jun 15; 48(6):543-9. PubMed ID: 8703557
    [Abstract] [Full Text] [Related]

  • 17. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
    Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA.
    J Endocrinol; 2000 May 15; 165(2):475-81. PubMed ID: 10810311
    [Abstract] [Full Text] [Related]

  • 18. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A, Ferone D, Lombardi G, Lastoria S.
    Clin Endocrinol (Oxf); 2002 Jun 15; 56(6):713-21. PubMed ID: 12072040
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation.
    Pawlikowski M, Radek M, Kunert-Radek J, Jaranowska M, Świętosławski J, Winczyk K.
    Endokrynol Pol; 2014 Jun 15; 65(5):382-6. PubMed ID: 25301489
    [Abstract] [Full Text] [Related]

  • 20. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM, Jacobi JM, Willgoss DA.
    Clin Endocrinol (Oxf); 1995 Jul 15; 43(1):79-85. PubMed ID: 7641414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.